{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T21:22:41Z","timestamp":1767907361701,"version":"3.49.0"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T00:00:00Z","timestamp":1688515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T00:00:00Z","timestamp":1688515200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006752","name":"Universidade do Porto","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006752","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Purinergic Signalling"],"published-print":{"date-parts":[[2024,4]]},"abstract":"<jats:title>\n                        <jats:bold>Abstract<\/jats:bold>\n                     <\/jats:title><jats:p>Sustained pressure overload and fibrosis of the right ventricle (RV) are the leading causes of mortality in pulmonary arterial hypertension (PAH). Although the role of adenosine in PAH has been attributed to the control of pulmonary vascular tone, cardiac reserve, and inflammatory processes, the involvement of the nucleoside in RV remodelling remains poorly understood. Conflicting results exist on targeting the low-affinity adenosine A<jats:sub>2B<\/jats:sub> receptor (A<jats:sub>2B<\/jats:sub>AR) for the treatment of PAH mostly because it displays dual roles in acute vs. chronic lung diseases. Herein, we investigated the role of the A<jats:sub>2B<\/jats:sub>AR in the viability\/proliferation and collagen production by cardiac fibroblasts (CFs) isolated from RVs of rats with monocrotaline (MCT)-induced PAH. CFs from MCT-treated rats display higher cell viability\/proliferation capacity and overexpress A<jats:sub>2B<\/jats:sub>AR compared to the cells from healthy littermates. The enzymatically stable adenosine analogue, 5\u2032-<jats:italic>N<\/jats:italic>-ethylcarboxamidoadenosine (NECA, 1\u201330 \u03bcM), concentration-dependently increased growth, and type I collagen production by CFs originated from control and PAH rats, but its effects were more prominent in cells from rats with PAH. Blockage of the A<jats:sub>2B<\/jats:sub>AR with PSB603 (100 nM), but not of the A<jats:sub>2A<\/jats:sub>AR with SCH442416 (100 nM), attenuated the proliferative effect of NECA in CFs from PAH rats. The A<jats:sub>2A<\/jats:sub>AR agonist, CGS21680 (3 and 10 nM), was virtually devoid of effect. Overall, data suggest that adenosine signalling via A<jats:sub>2B<\/jats:sub>AR may contribute to RV overgrowth secondary to PAH. Therefore, blockage of the A<jats:sub>2A<\/jats:sub>AR may be a valuable therapeutic alternative to mitigate cardiac remodelling and prevent right heart failure in PAH patients.<\/jats:p>","DOI":"10.1007\/s11302-023-09952-z","type":"journal-article","created":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T02:02:00Z","timestamp":1688522520000},"page":"163-179","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Blockage of the adenosine A2B receptor prevents cardiac fibroblasts overgrowth in rats with pulmonary arterial hypertension"],"prefix":"10.1007","volume":"20","author":[{"given":"Mafalda","family":"Bessa-Gon\u00e7alves","sequence":"first","affiliation":[]},{"given":"Bruno","family":"Bragan\u00e7a","sequence":"additional","affiliation":[]},{"given":"Eduardo","family":"Martins-Dias","sequence":"additional","affiliation":[]},{"given":"Adriana","family":"Vinhas","sequence":"additional","affiliation":[]},{"given":"Mariana","family":"Certal","sequence":"additional","affiliation":[]},{"given":"T\u00e2nia","family":"Rodrigues","sequence":"additional","affiliation":[]},{"given":"F\u00e1tima","family":"Ferreirinha","sequence":"additional","affiliation":[]},{"given":"Maria Adelina","family":"Costa","sequence":"additional","affiliation":[]},{"given":"Paulo","family":"Correia-de-S\u00e1","sequence":"additional","affiliation":[]},{"given":"Ana Patr\u00edcia","family":"Fontes-Sousa","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2023,7,5]]},"reference":[{"key":"9952_CR1","doi-asserted-by":"crossref","unstructured":"Vonk Noordegraaf A et al (2019) Pathophysiology of the right ventricle and of the pulmonary circulation in pulmonary hypertension: an update. Eur Respir J 53(1)","DOI":"10.1183\/13993003.01900-2018"},{"key":"9952_CR2","doi-asserted-by":"crossref","unstructured":"Beckmann T et al (2022) Strategizing drug therapies in pulmonary hypertension for improved outcomes. Pharmaceuticals (Basel) 15(10)","DOI":"10.3390\/ph15101242"},{"key":"9952_CR3","doi-asserted-by":"publisher","first-page":"121792","DOI":"10.1016\/j.ijpharm.2022.121792","volume":"621","author":"S Dhoble","year":"2022","unstructured":"Dhoble S et al (2022) Comprehensive review on novel targets and emerging therapeutic modalities for pulmonary arterial hypertension. Int J Pharm 621:121792","journal-title":"Int J Pharm"},{"issue":"1","key":"9952_CR4","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/bph.15016","volume":"178","author":"N Sommer","year":"2021","unstructured":"Sommer N et al (2021) Current and future treatments of pulmonary arterial hypertension. Br J Pharmacol 178(1):6\u201330","journal-title":"Br J Pharmacol"},{"key":"9952_CR5","doi-asserted-by":"crossref","unstructured":"Liu Y et al (2021) Inhibiting miR-1 attenuates pulmonary arterial hypertension in rats. Mol Med Rep 23(4)","DOI":"10.3892\/mmr.2021.11922"},{"key":"9952_CR6","doi-asserted-by":"publisher","first-page":"4382999","DOI":"10.1155\/2022\/4382999","volume":"2022","author":"Y Tang","year":"2022","unstructured":"Tang Y et al (2022) MicroRNA-325-3p targets human epididymis protein 4 to relieve right ventricular fibrosis in rats with pulmonary arterial hypertension. Cardiovasc Ther 2022:4382999","journal-title":"Cardiovasc Ther"},{"key":"9952_CR7","doi-asserted-by":"publisher","first-page":"641310","DOI":"10.3389\/fphys.2021.641310","volume":"12","author":"D Sharifi Kia","year":"2021","unstructured":"Sharifi Kia D, Kim K, Simon MA (2021) Current understanding of the right ventricle structure and function in pulmonary arterial hypertension. Front Physiol 12:641310","journal-title":"Front Physiol"},{"issue":"2","key":"9952_CR8","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1124\/pharmrev.121.000445","volume":"74","author":"AP IJzerman","year":"2022","unstructured":"IJzerman AP et al (2022) International Union of Basic and Clinical Pharmacology. CXII: adenosine receptors: a further update. Pharmacol Rev 74(2):340\u2013372","journal-title":"Pharmacol Rev"},{"issue":"6","key":"9952_CR9","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1016\/j.drudis.2018.05.005","volume":"23","author":"M Bessa-Goncalves","year":"2018","unstructured":"Bessa-Goncalves M et al (2018) Is the adenosine A(2B) \u2018biased\u2019 receptor a valuable target for the treatment of pulmonary arterial hypertension? Drug Discov Today 23(6):1285\u20131292","journal-title":"Drug Discov Today"},{"key":"9952_CR10","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.pharmthera.2019.01.003","volume":"198","author":"EA Vecchio","year":"2019","unstructured":"Vecchio EA, White PJ, May LT (2019) The adenosine A(2B) G protein-coupled receptor: recent advances and therapeutic implications. Pharmacol Ther 198:20\u201333","journal-title":"Pharmacol Ther"},{"issue":"3","key":"9952_CR11","doi-asserted-by":"publisher","first-page":"2003957","DOI":"10.1183\/13993003.03957-2020","volume":"58","author":"EE Colin","year":"2021","unstructured":"Colin EE et al (2021) Endothelial cells in the pathogenesis of pulmonary arterial hypertension. Eur Respir J 58(3):2003957","journal-title":"Eur Respir J"},{"issue":"5","key":"9952_CR12","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1002\/jcp.22458","volume":"226","author":"MA Costa","year":"2011","unstructured":"Costa MA et al (2011) On the role of subtype selective adenosine receptor agonists during proliferation and osteogenic differentiation of human primary bone marrow stromal cells. J Cell Physiol 226(5):1353\u20131366","journal-title":"J Cell Physiol"},{"issue":"38","key":"9952_CR13","doi-asserted-by":"publisher","first-page":"27571","DOI":"10.1074\/jbc.M113.460865","volume":"288","author":"AR Pinheiro","year":"2013","unstructured":"Pinheiro AR et al (2013) Histamine induces ATP release from human subcutaneous fibroblasts, via pannexin-1 hemichannels, leading to Ca2+ mobilization and cell proliferation. J Biol Chem 288(38):27571\u201327583","journal-title":"J Biol Chem"},{"issue":"5","key":"9952_CR14","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.ceca.2015.08.004","volume":"58","author":"M Certal","year":"2015","unstructured":"Certal M et al (2015) Calcium signaling and the novel anti-proliferative effect of the UTP-sensitive P2Y11 receptor in rat cardiac myofibroblasts. Cell Calcium 58(5):518\u2013533","journal-title":"Cell Calcium"},{"issue":"5","key":"9952_CR15","doi-asserted-by":"publisher","first-page":"C1171","DOI":"10.1152\/ajpcell.00290.2008","volume":"296","author":"SA Epperson","year":"2009","unstructured":"Epperson SA et al (2009) Adenosine receptors and second messenger signaling pathways in rat cardiac fibroblasts. Am J Physiol Cell Physiol 296(5):C1171\u2013C1177","journal-title":"Am J Physiol Cell Physiol"},{"key":"9952_CR16","doi-asserted-by":"publisher","first-page":"858","DOI":"10.3389\/fphar.2017.00858","volume":"8","author":"AKN Alencar","year":"2017","unstructured":"Alencar AKN et al (2017) Adenosine receptors as drug targets for treatment of pulmonary arterial hypertension. Front Pharmacol 8:858","journal-title":"Front Pharmacol"},{"issue":"4","key":"9952_CR17","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s13402-011-0035-7","volume":"34","author":"AM Hadi","year":"2011","unstructured":"Hadi AM et al (2011) Rapid quantification of myocardial fibrosis: a new macro-based automated analysis. Cell Oncol (Dordr) 34(4):343\u2013354","journal-title":"Cell Oncol (Dordr)"},{"issue":"9","key":"9952_CR18","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1369\/0022155415592180","volume":"63","author":"R Marcos","year":"2015","unstructured":"Marcos R, Braganca B, Fontes-Sousa AP (2015) Image analysis or stereology: which to choose for quantifying fibrosis? J Histochem Cytochem 63(9):734\u2013736","journal-title":"J Histochem Cytochem"},{"issue":"7400","key":"9952_CR19","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/nature11139","volume":"485","author":"K Song","year":"2012","unstructured":"Song K et al (2012) Heart repair by reprogramming non-myocytes with cardiac transcription factors. Nature 485(7400):599\u2013604","journal-title":"Nature"},{"issue":"6","key":"9952_CR20","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1002\/jcp.25656","volume":"232","author":"M Certal","year":"2016","unstructured":"Certal M et al (2016) ADP-induced Ca2+ signaling and proliferation of rat ventricular myofibroblasts depend on phospholipase C-linked TRP channels activation within lipid rafts. J Cell Physiol 232(6):1511\u20131526","journal-title":"J Cell Physiol"},{"issue":"3","key":"9952_CR21","doi-asserted-by":"publisher","first-page":"651","DOI":"10.3390\/cells9030651","volume":"9","author":"C Herman-de-Sousa","year":"2020","unstructured":"Herman-de-Sousa C et al (2020) Opposing effects of adenosine and inosine in human subcutaneous fibroblasts may be regulated by third party ADA cell providers. Cells 9(3):651","journal-title":"Cells"},{"key":"9952_CR22","doi-asserted-by":"publisher","first-page":"121080","DOI":"10.1016\/j.lfs.2022.121080","volume":"310","author":"C Herman-de-Sousa","year":"2022","unstructured":"Herman-de-Sousa C et al (2022) A(2A) receptor-induced overexpression of pannexin-1 channels indirectly mediates adenosine fibrogenic actions by favouring ATP release from human subcutaneous fibroblasts. Life Sci 310:121080","journal-title":"Life Sci"},{"issue":"4","key":"9952_CR23","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s004180050447","volume":"112","author":"H Tullberg-Reinert","year":"1999","unstructured":"Tullberg-Reinert H, Jundt G (1999) In situ measurement of collagen synthesis by human bone cells with a sirius red-based colorimetric microassay: effects of transforming growth factor beta2 and ascorbic acid 2-phosphate. Histochem Cell Biol 112(4):271\u2013276","journal-title":"Histochem Cell Biol"},{"issue":"7","key":"9952_CR24","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1111\/j.1476-5381.2009.00119.x","volume":"156","author":"SM Alqallaf","year":"2009","unstructured":"Alqallaf SM, Evans BA, Kidd EJ (2009) Atypical P2X receptor pharmacology in two human osteoblast-like cell lines. Br J Pharmacol 156(7):1124\u20131135","journal-title":"Br J Pharmacol"},{"issue":"6","key":"9952_CR25","doi-asserted-by":"publisher","first-page":"2694","DOI":"10.1002\/jcp.23014","volume":"227","author":"JB Noronha-Matos","year":"2012","unstructured":"Noronha-Matos JB et al (2012) Role of ecto-NTPDases on UDP-sensitive P2Y(6) receptor activation during osteogenic differentiation of primary bone marrow stromal cells from postmenopausal women. J Cell Physiol 227(6):2694\u20132709","journal-title":"J Cell Physiol"},{"issue":"13","key":"9952_CR26","doi-asserted-by":"publisher","first-page":"3994","DOI":"10.1021\/jm900413e","volume":"52","author":"T Borrmann","year":"2009","unstructured":"Borrmann T et al (2009) 1-alkyl-8-(piperazine-1-sulfonyl)phenylxanthines: development and characterization of adenosine A2B receptor antagonists and a new radioligand with subnanomolar affinity and subtype specificity. J Med Chem 52(13):3994\u20134006","journal-title":"J Med Chem"},{"issue":"6","key":"9952_CR27","doi-asserted-by":"publisher","first-page":"H3685","DOI":"10.1152\/ajpheart.00819.2007","volume":"293","author":"J Zheng","year":"2007","unstructured":"Zheng J et al (2007) Protective roles of adenosine A1, A2A, and A3 receptors in skeletal muscle ischemia and reperfusion injury. Am J Physiol Heart Circ Physiol 293(6):H3685\u2013H3691","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"5","key":"9952_CR28","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/S0002-9149(96)00372-4","volume":"78","author":"SP Bradley","year":"1996","unstructured":"Bradley SP et al (1996) Right ventricular pathology in chronic pulmonary hypertension. Am J Cardiol 78(5):584\u2013587","journal-title":"Am J Cardiol"},{"issue":"5","key":"9952_CR29","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1002\/ar.20922","volume":"293","author":"EC Goldsmith","year":"2010","unstructured":"Goldsmith EC et al (2010) The collagen receptor DDR2 is expressed during early cardiac development. Anat Rec (Hoboken) 293(5):762\u2013769","journal-title":"Anat Rec (Hoboken)"},{"issue":"3","key":"9952_CR30","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1017\/S1431927605050518","volume":"11","author":"MO Morales","year":"2005","unstructured":"Morales MO, Price RL, Goldsmith EC (2005) Expression of discoidin domain receptor 2 (DDR2) in the developing heart. Microsc Microanal 11(3):260\u2013267","journal-title":"Microsc Microanal"},{"issue":"1-2","key":"9952_CR31","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1023\/A:1006848512174","volume":"172","author":"AE Agocha","year":"1997","unstructured":"Agocha AE, Eghbali-Webb M (1997) A simple method for preparation of cultured cardiac fibroblasts from adult human ventricular tissue. Mol Cell Biochem 172(1-2):195\u2013198","journal-title":"Mol Cell Biochem"},{"key":"9952_CR32","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1146\/annurev.pharmtox.45.120403.095802","volume":"45","author":"RD Brown","year":"2005","unstructured":"Brown RD et al (2005) The cardiac fibroblast: therapeutic target in myocardial remodeling and failure. Annu Rev Pharmacol Toxicol 45:657\u2013687","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"4","key":"9952_CR33","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1097\/FJC.0b013e3182137e17","volume":"57","author":"S Rohr","year":"2011","unstructured":"Rohr S (2011) Cardiac fibroblasts in cell culture systems: myofibroblasts all along? J Cardiovasc Pharmacol 57(4):389\u2013399","journal-title":"J Cardiovasc Pharmacol"},{"issue":"4","key":"9952_CR34","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1164\/rccm.200506-869OC","volume":"173","author":"K Varani","year":"2006","unstructured":"Varani K et al (2006) Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 173(4):398\u2013406","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"9952_CR35","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1124\/jpet.113.210849","volume":"349","author":"S Hinz","year":"2014","unstructured":"Hinz S et al (2014) BAY60-6583 acts as a partial agonist at adenosine A2B receptors. J Pharmacol Exp Ther 349(3):427\u2013436","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"9952_CR36","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.ccl.2020.01.009","volume":"38","author":"RA Thandavarayan","year":"2020","unstructured":"Thandavarayan RA, Chitturi KR, Guha A (2020) Pathophysiology of acute and chronic right heart failure. Cardiol Clin 38(2):149\u2013160","journal-title":"Cardiol Clin"},{"key":"9952_CR37","doi-asserted-by":"crossref","unstructured":"Sabbah BN et al (2023) Heart failure in systemic right ventricle: mechanisms and therapeutic options. Frontiers in Cardiovascular Medicine:9","DOI":"10.3389\/fcvm.2022.1064196"},{"issue":"6","key":"9952_CR38","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/j.chest.2017.10.007","volume":"152","author":"NS Hill","year":"2017","unstructured":"Hill NS, Gillespie MN, McMurtry IF (2017) Fifty years of monocrotaline-induced pulmonary hypertension: what has it meant to the field? Chest 152(6):1106\u20131108","journal-title":"Chest"},{"key":"9952_CR39","doi-asserted-by":"publisher","unstructured":"Jasenovec T et al (2022) Monocrotaline-induced pulmonary arterial hypertension and bosentan treatment in rats: focus on plasma and erythrocyte parameters. Pharmaceuticals 15. https:\/\/doi.org\/10.3390\/ph15101227","DOI":"10.3390\/ph15101227"},{"issue":"2","key":"9952_CR40","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.1080\/21655979.2021.2017652","volume":"13","author":"T Qin","year":"2022","unstructured":"Qin T et al (2022) Protective effects of Dapagliflozin on the vulnerability of ventricular arrhythmia in rats with pulmonary artery hypertension induced by monocrotaline. Bioengineered 13(2):2697\u20132709","journal-title":"Bioengineered"},{"issue":"4","key":"9952_CR41","doi-asserted-by":"publisher","first-page":"681","DOI":"10.7150\/ijms.69289","volume":"19","author":"M Yu","year":"2022","unstructured":"Yu M et al (2022) Paeoniflorin attenuates monocrotaline-induced pulmonary arterial hypertension in rats by suppressing TAK1-MAPK\/NF-\u03baB pathways. Int J Med Sci 19(4):681\u2013694","journal-title":"Int J Med Sci"},{"issue":"20","key":"9952_CR42","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.1016\/j.jacc.2019.02.067","volume":"73","author":"Y Dai","year":"2019","unstructured":"Dai Y et al (2019) Immunotherapy of endothelin-1 receptor type A for pulmonary arterial hypertension. J Am Coll Cardiol 73(20):2567\u20132580","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"9952_CR43","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1186\/s12967-020-02440-7","volume":"18","author":"MK Holda","year":"2020","unstructured":"Holda MK et al (2020) Changes in heart morphometric parameters over the course of a monocrotaline-induced pulmonary arterial hypertension rat model. J Transl Med 18(1):262","journal-title":"J Transl Med"},{"issue":"5","key":"9952_CR44","doi-asserted-by":"publisher","first-page":"H2424","DOI":"10.1152\/ajpheart.00369.2006","volume":"291","author":"MH Hessel","year":"2006","unstructured":"Hessel MH et al (2006) Characterization of right ventricular function after monocrotaline-induced pulmonary hypertension in the intact rat. Am J Physiol Heart Circ Physiol 291(5):H2424\u2013H2430","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"9952_CR45","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s10741-016-9526-y","volume":"21","author":"MC van de Veerdonk","year":"2016","unstructured":"van de Veerdonk MC, Bogaard HJ, Voelkel NF (2016) The right ventricle and pulmonary hypertension. Heart Fail Rev 21:259\u2013271","journal-title":"Heart Fail Rev"},{"issue":"4","key":"9952_CR46","doi-asserted-by":"publisher","first-page":"H702","DOI":"10.1152\/ajpheart.00046.2021","volume":"321","author":"ED Kwan","year":"2021","unstructured":"Kwan ED et al (2021) Distinct time courses and mechanics of right ventricular hypertrophy and diastolic stiffening in a male rat model of pulmonary arterial hypertension. Am J Physiol Heart Circ Physiol 321(4):H702\u2013H715","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"9952_CR47","doi-asserted-by":"publisher","first-page":"14351","DOI":"10.1038\/s41598-020-71264-8","volume":"10","author":"MK Ho\u0142da","year":"2020","unstructured":"Ho\u0142da MK et al (2020) Myocardial proteomic profile in pulmonary arterial hypertension. Sci Rep 10(1):14351","journal-title":"Sci Rep"},{"issue":"1","key":"9952_CR48","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/nrcardio.2009.199","volume":"7","author":"SW van den Borne","year":"2010","unstructured":"van den Borne SW et al (2010) Myocardial remodeling after infarction: the role of myofibroblasts. Nat Rev Cardiol 7(1):30\u201337","journal-title":"Nat Rev Cardiol"},{"issue":"10","key":"9952_CR49","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1161\/01.CIR.101.10.1130","volume":"101","author":"H Kawano","year":"2000","unstructured":"Kawano H et al (2000) Angiotensin II has multiple profibrotic effects in human cardiac fibroblasts. Circulation 101(10):1130\u20131137","journal-title":"Circulation"},{"issue":"2","key":"9952_CR50","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1161\/hy0202.103268","volume":"39","author":"VV Petrov","year":"2002","unstructured":"Petrov VV, Fagard RH, Lijnen PJ (2002) Stimulation of collagen production by transforming growth factor-beta1 during differentiation of cardiac fibroblasts to myofibroblasts. Hypertension 39(2):258\u2013263","journal-title":"Hypertension"},{"issue":"5","key":"9952_CR51","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.21037\/cdt-20-348","volume":"10","author":"C Inampudi","year":"2020","unstructured":"Inampudi C et al (2020) Treatment of right ventricular dysfunction and heart failure in pulmonary arterial hypertension. Cardiovasc Diagn Ther 10(5):1659\u20131674","journal-title":"Cardiovasc Diagn Ther"},{"issue":"5","key":"9952_CR52","doi-asserted-by":"publisher","first-page":"e019338","DOI":"10.1161\/JAHA.120.019338","volume":"10","author":"C Hall","year":"2021","unstructured":"Hall C et al (2021) Complex relationship between cardiac fibroblasts and cardiomyocytes in health and disease. J Am Heart Assoc 10(5):e019338","journal-title":"J Am Heart Assoc"},{"key":"9952_CR53","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.3390\/cells11091386","volume":"11","author":"H Venugopal","year":"2022","unstructured":"Venugopal H et al (2022) Properties and functions of fibroblasts and myofibroblasts in myocardial infarction. Cells 11:1386. https:\/\/doi.org\/10.3390\/cells11091386","journal-title":"Cells"},{"key":"9952_CR54","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.phrs.2015.07.001","volume":"101","author":"G Diaz-Araya","year":"2015","unstructured":"Diaz-Araya G et al (2015) Cardiac fibroblasts as sentinel cells in cardiac tissue: receptors, signaling pathways and cellular functions. Pharmacol Res 101:30\u201340","journal-title":"Pharmacol Res"},{"key":"9952_CR55","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.3390\/jcm9051366","volume":"9","author":"R Guieu","year":"2020","unstructured":"Guieu R et al (2020) Adenosine and the cardiovascular system: the good and the bad. J Clin Med 9:1366. https:\/\/doi.org\/10.3390\/jcm9051366","journal-title":"J Clin Med"},{"issue":"6","key":"9952_CR56","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1124\/mol.58.6.1349","volume":"58","author":"MW Beukers","year":"2000","unstructured":"Beukers MW et al (2000) Why are A(2B) receptors low-affinity adenosine receptors? Mutation of Asn273 to Tyr increases affinity of human A(2B) receptor for 2-(1-Hexynyl)adenosine. Mol Pharmacol 58(6):1349\u20131356","journal-title":"Mol Pharmacol"},{"issue":"6","key":"9952_CR57","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1165\/rcmb.2013-0089OC","volume":"49","author":"H Karmouty-Quintana","year":"2013","unstructured":"Karmouty-Quintana H et al (2013) Adenosine A2B receptor and hyaluronan modulate pulmonary hypertension associated with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 49(6):1038\u20131047","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"2","key":"9952_CR58","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s00109-013-0997-1","volume":"91","author":"H Karmouty-Quintana","year":"2013","unstructured":"Karmouty-Quintana H, Xia Y, Blackburn MR (2013) Adenosine signaling during acute and chronic disease states. J Mol Med (Berl) 91(2):173\u2013181","journal-title":"J Mol Med (Berl)"},{"issue":"1","key":"9952_CR59","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.pharmthera.2013.06.002","volume":"140","author":"JP Headrick","year":"2013","unstructured":"Headrick JP et al (2013) Cardiovascular adenosine receptors: expression, actions and interactions. Pharmacol Ther 140(1):92\u2013111","journal-title":"Pharmacol Ther"},{"issue":"2","key":"9952_CR60","doi-asserted-by":"publisher","first-page":"204","DOI":"10.3390\/biomedicines9020204","volume":"9","author":"MC Procopio","year":"2021","unstructured":"Procopio MC et al (2021) Role of adenosine and purinergic receptors in myocardial infarction: focus on different signal transduction pathways. Biomedicines 9(2):204","journal-title":"Biomedicines"},{"issue":"9","key":"9952_CR61","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1007\/s00424-018-2158-4","volume":"470","author":"K Imoto","year":"2018","unstructured":"Imoto K, Okada M, Yamawaki H (2018) Characterization of fibroblasts from hypertrophied right ventricle of pulmonary hypertensive rats. Pflugers Arch 470(9):1405\u20131417","journal-title":"Pflugers Arch"},{"key":"9952_CR62","doi-asserted-by":"publisher","first-page":"828","DOI":"10.3389\/fphys.2018.00828","volume":"9","author":"L Tian","year":"2018","unstructured":"Tian L et al (2018) Increased Drp1-mediated mitochondrial fission promotes proliferation and collagen production by right ventricular fibroblasts in experimental pulmonary arterial hypertension. Front Physiol 9:828","journal-title":"Front Physiol"},{"issue":"12","key":"9952_CR63","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1161\/CIRCRESAHA.120.316443","volume":"126","author":"L Tian","year":"2020","unstructured":"Tian L et al (2020) Epigenetic metabolic reprogramming of right ventricular fibroblasts in pulmonary arterial hypertension: a pyruvate dehydrogenase kinase-dependent shift in mitochondrial metabolism promotes right ventricular fibrosis. Circ Res 126(12):1723\u20131745","journal-title":"Circ Res"},{"key":"9952_CR64","first-page":"3293584","volume":"2018","author":"N Rai","year":"2018","unstructured":"Rai N et al (2018) Effect of riociguat and sildenafil on right heart remodeling and function in pressure overload induced model of pulmonary arterial banding. Biomed Res Int 2018:3293584","journal-title":"Biomed Res Int"},{"issue":"3","key":"9952_CR65","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1080\/10799893.2016.1247860","volume":"37","author":"S Del Ry","year":"2017","unstructured":"Del Ry S et al (2017) Adenosine receptors expression in cardiac fibroblasts of patients with left ventricular dysfunction due to valvular disease. J Recept Signal Transduct Res 37(3):283\u2013289","journal-title":"J Recept Signal Transduct Res"},{"issue":"4","key":"9952_CR66","first-page":"705","volume":"56","author":"J Linden","year":"1999","unstructured":"Linden J et al (1999) Characterization of human A(2B) adenosine receptors: radioligand binding, western blotting, and coupling to G(q) in human embryonic kidney 293 cells and HMC-1 mast cells. Mol Pharmacol 56(4):705\u2013713","journal-title":"Mol Pharmacol"},{"issue":"2","key":"9952_CR67","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1161\/01.HYP.37.2.716","volume":"37","author":"RK Dubey","year":"2001","unstructured":"Dubey RK et al (2001) A(2b) receptors mediate the antimitogenic effects of adenosine in cardiac fibroblasts. Hypertension 37(2):716\u2013721","journal-title":"Hypertension"},{"issue":"11","key":"9952_CR68","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1177\/1535370215584939","volume":"240","author":"X Du","year":"2015","unstructured":"Du X et al (2015) Adenosine A2B receptor stimulates angiogenesis by inducing VEGF and eNOS in human microvascular endothelial cells. Exp Biol Med (Maywood) 240(11):1472\u20131479","journal-title":"Exp Biol Med (Maywood)"},{"issue":"3","key":"9952_CR69","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s11302-015-9460-9","volume":"11","author":"MW Alnouri","year":"2015","unstructured":"Alnouri MW et al (2015) Selectivity is species-dependent: characterization of standard agonists and antagonists at human, rat, and mouse adenosine receptors. Purinergic Signal 11(3):389\u2013407","journal-title":"Purinergic Signal"},{"issue":"8","key":"9952_CR70","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1172\/JCI27303","volume":"116","author":"CX Sun","year":"2006","unstructured":"Sun CX et al (2006) Role of A2B adenosine receptor signaling in adenosine-dependent pulmonary inflammation and injury. J Clin Invest 116(8):2173\u20132182","journal-title":"J Clin Invest"},{"issue":"6","key":"9952_CR71","doi-asserted-by":"publisher","first-page":"4397","DOI":"10.3892\/mmr.2015.3320","volume":"11","author":"J Tang","year":"2015","unstructured":"Tang J et al (2015) Effects of A2BR on the biological behavior of mouse renal fibroblasts during hypoxia. Mol Med Rep 11(6):4397\u20134402","journal-title":"Mol Med Rep"},{"issue":"12","key":"9952_CR72","doi-asserted-by":"publisher","first-page":"2891","DOI":"10.1002\/jcp.25043","volume":"230","author":"A Eisenstein","year":"2015","unstructured":"Eisenstein A, Patterson S, Ravid K (2015) The many faces of the A2b adenosine receptor in cardiovascular and metabolic diseases. J Cell Physiol 230(12):2891\u20132897","journal-title":"J Cell Physiol"},{"issue":"7","key":"9952_CR73","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1038\/sj.bjp.0707319","volume":"151","author":"P Kalk","year":"2007","unstructured":"Kalk P et al (2007) The adenosine A1 receptor antagonist SLV320 reduces myocardial fibrosis in rats with 5\/6 nephrectomy without affecting blood pressure. Br J Pharmacol 151(7):1025\u20131032","journal-title":"Br J Pharmacol"},{"issue":"2","key":"9952_CR74","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s11302-016-9498-3","volume":"12","author":"G Shaikh","year":"2016","unstructured":"Shaikh G, Cronstein B (2016) Signaling pathways involving adenosine A2A and A2B receptors in wound healing and fibrosis. Purinergic Signal 12(2):191\u2013197","journal-title":"Purinergic Signal"},{"issue":"12","key":"9952_CR75","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.1016\/j.peptides.2008.09.003","volume":"29","author":"K Yuan","year":"2008","unstructured":"Yuan K et al (2008) Stimulation of ANP secretion by 2-Cl-IB-MECA through A(3) receptor and CaMKII. Peptides 29(12):2216\u20132224","journal-title":"Peptides"},{"issue":"6","key":"9952_CR76","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1161\/01.HYP.0000190041.61737.fd","volume":"46","author":"K Yuan","year":"2005","unstructured":"Yuan K et al (2005) Adenosine-stimulated atrial natriuretic peptide release through A1 receptor subtype. Hypertension 46(6):1381\u20131387","journal-title":"Hypertension"},{"issue":"3","key":"9952_CR77","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1124\/jpet.111.191288","volume":"343","author":"S Toldo","year":"2012","unstructured":"Toldo S et al (2012) GS-6201, a selective blocker of the A2B adenosine receptor, attenuates cardiac remodeling after acute myocardial infarction in the mouse. J Pharmacol Exp Ther 343(3):587\u2013595","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"9952_CR78","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.hrthm.2013.10.023","volume":"11","author":"H Zhang","year":"2014","unstructured":"Zhang H et al (2014) Blockade of A2B adenosine receptor reduces left ventricular dysfunction and ventricular arrhythmias 1 week after myocardial infarction in the rat model. Heart Rhythm 11(1):101\u2013109","journal-title":"Heart Rhythm"},{"issue":"8","key":"9952_CR79","doi-asserted-by":"publisher","first-page":"S65","DOI":"10.1016\/j.cardfail.2011.06.234","volume":"17","author":"H Zhong","year":"2011","unstructured":"Zhong H, Belardinelli L, Zeng D (2011) Pro-fibrotic role of the A2B adenosine receptor in human cardiac fibroblasts. J Card Fail 17(8):S65","journal-title":"J Card Fail"},{"issue":"6","key":"9952_CR80","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1096\/fj.11-200907","volume":"26","author":"H Karmouty-Quintana","year":"2012","unstructured":"Karmouty-Quintana H et al (2012) The A2B adenosine receptor modulates pulmonary hypertension associated with interstitial lung disease. FASEB J 26(6):2546\u20132557","journal-title":"FASEB J"},{"issue":"26","key":"9952_CR81","doi-asserted-by":"publisher","first-page":"19040","DOI":"10.1074\/jbc.M113.466102","volume":"288","author":"D Lu","year":"2013","unstructured":"Lu D, Insel PA (2013) Hydrolysis of extracellular ATP by ectonucleoside triphosphate diphosphohydrolase (ENTPD) establishes the set point for fibrotic activity of cardiac fibroblasts. J Biol Chem 288(26):19040\u201319049","journal-title":"J Biol Chem"},{"issue":"6","key":"9952_CR82","doi-asserted-by":"publisher","first-page":"H2478","DOI":"10.1152\/ajpheart.00217.2004","volume":"287","author":"Y Chen","year":"2004","unstructured":"Chen Y et al (2004) Functional effects of enhancing or silencing adenosine A2b receptors in cardiac fibroblasts. Am J Physiol Heart Circ Physiol 287(6):H2478\u2013H2486","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"18","key":"9952_CR83","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1161\/CIRCULATIONAHA.106.630087","volume":"114","author":"M Wakeno","year":"2006","unstructured":"Wakeno M et al (2006) Long-term stimulation of adenosine A2b receptors begun after myocardial infarction prevents cardiac remodeling in rats. Circulation 114(18):1923\u20131932","journal-title":"Circulation"},{"issue":"4","key":"9952_CR84","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1161\/01.HYP.31.4.943","volume":"31","author":"RK Dubey","year":"1998","unstructured":"Dubey RK, Gillespie DG, Jackson EK (1998) Adenosine inhibits collagen and protein synthesis in cardiac fibroblasts: role of A2B receptors. Hypertension 31(4):943\u2013948","journal-title":"Hypertension"},{"key":"9952_CR85","doi-asserted-by":"publisher","first-page":"428","DOI":"10.3389\/fphar.2017.00428","volume":"8","author":"S Phosri","year":"2017","unstructured":"Phosri S et al (2017) Stimulation of adenosine A(2B) receptor inhibits endothelin-1-induced cardiac fibroblast proliferation and alpha-smooth muscle actin synthesis through the cAMP\/Epac\/PI3K\/Akt-signaling pathway. Front Pharmacol 8:428","journal-title":"Front Pharmacol"},{"key":"9952_CR86","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.bcp.2016.08.007","volume":"117","author":"EA Vecchio","year":"2016","unstructured":"Vecchio EA et al (2016) The hybrid molecule, VCP746, is a potent adenosine A2B receptor agonist that stimulates anti-fibrotic signalling. Biochem Pharmacol 117:46\u201356","journal-title":"Biochem Pharmacol"},{"issue":"7","key":"9952_CR87","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1089\/ten.tec.2017.0169","volume":"23","author":"Y Zhou","year":"2017","unstructured":"Zhou Y, Richards AM, Wang P (2017) Characterization and standardization of cultured cardiac fibroblasts for ex vivo models of heart fibrosis and heart ischemia. Tissue Eng Part C Methods 23(7):422\u2013433","journal-title":"Tissue Eng Part C Methods"}],"container-title":["Purinergic Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11302-023-09952-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11302-023-09952-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11302-023-09952-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T09:32:48Z","timestamp":1712309568000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11302-023-09952-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,5]]},"references-count":87,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["9952"],"URL":"https:\/\/doi.org\/10.1007\/s11302-023-09952-z","relation":{},"ISSN":["1573-9538","1573-9546"],"issn-type":[{"value":"1573-9538","type":"print"},{"value":"1573-9546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,5]]},"assertion":[{"value":"16 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Animal handling and experiments were performed following the Guide for the Care and Use of Laboratory Animals, published by the US National Institutes of Health (NIH Publication No. 85-23, Revised 2011), and followed the European Communities Council Directive (86\/609\/EEC). All procedures involving animals were approved by the competent national authority Dire\u00e7\u00e3o Geral de Alimenta\u00e7\u00e3o e Veterin\u00e1ria, and by the Animal Welfare Committee of ICBAS (No. 224\/2017). All efforts were made to minimize animal suffering and to reduce the number of animals used according to the ARRIVE guidelines. This exploratory study was not pre-registered.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}